Sartorius Stedim Biotech Share Price

Equities

DIM

FR0013154002

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris 13:10:05 25/06/2024 BST 5-day change 1st Jan Change
157 EUR -1.54% Intraday chart for Sartorius Stedim Biotech -11.47% -34.45%

Financials

Sales 2024 * 2.94B 3.14B 248B Sales 2025 * 3.33B 3.56B 281B Capitalization 15.52B 16.62B 1,311B
Net income 2024 * 335M 359M 28.3B Net income 2025 * 451M 483M 38.1B EV / Sales 2024 * 6.06 x
Net Debt 2024 * 2.27B 2.43B 192B Net Debt 2025 * 2.16B 2.31B 182B EV / Sales 2025 * 5.31 x
P/E ratio 2024 *
44.9 x
P/E ratio 2025 *
32.3 x
Employees 10,493
Yield 2024 *
0.46%
Yield 2025 *
0.68%
Free-Float 31.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.54%
1 week-11.47%
Current month-14.04%
1 month-16.33%
3 months-42.11%
6 months-34.42%
Current year-34.45%
More quotes
1 week
146.45
Extreme 146.45
176.20
1 month
146.45
Extreme 146.45
194.65
Current year
146.45
Extreme 146.45
281.00
1 year
146.45
Extreme 146.45
287.80
3 years
146.45
Extreme 146.45
551.00
5 years
120.60
Extreme 120.6
551.00
10 years
20.00
Extreme 20
551.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 25/03/19
Chairman 59 28/06/07
Chief Tech/Sci/R&D Officer 59 28/04/09
Members of the board TitleAgeSince
Director/Board Member 62 28/06/07
Chairman 59 28/06/07
Director/Board Member 67 06/04/15
More insiders
Date Price Change Volume
25/06/24 157 -1.54% 20 359
24/06/24 159.4 +1.30% 57,355
21/06/24 157.4 +0.41% 260,689
20/06/24 156.8 +2.48% 153,655
19/06/24 153 -13.76% 319,992

Real-time Euronext Paris, June 25, 2024 at 01:10 pm

More quotes
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
159.4 EUR
Average target price
248.8 EUR
Spread / Average Target
+56.06%
Consensus